The effect of conversion from cyclosporine to tacrolimus on gingival hyperplasia, hirsutism and cholesterol

Micah Thorp, Angelo Demattos, William Bennett, John Barry, Douglas Norman

Research output: Contribution to journalArticle

85 Citations (Scopus)

Abstract

The use of cyclosporine for immunosuppression in renal transplantation allograft recipients is associated with hypertrichosis, gingival hyperplasia, and hypercholesterolemia. Conversion of patients to tacrolimus may lead to an improvement in these effects with minimal risk of rejection or allograft dysfunction. Methods. Sixteen renal transplant recipients were prospectively converted from CsA to tacrolimus and followed for 1 year. Gingival hyperplasia index, total cholesterol, and blood pressure were recorded at the outset, 4-, 8-, and 12-month intervals. Glomerular filtration rate was checked before conversion and 1 year later. Photographs documenting hypertrichosis were taken before conversion and 1 year later. Adverse effects from tacrolimus were recorded at 4, 8, and 12 months. Results. Twelve patients with hypertrichosis noted rapid improvement. Mean gingival hyperplasia index decreased from 24 to 6; mean total cholesterol decreased from 237 to 195. Glomerular filtration rate was essentially unchanged (56 to 54). One episode of rejection occurred, three patients developed diarrhea, three noted headaches, and one had a tremor. Conclusion. If carefully monitored, patients suffering adverse effects secondary to cyclosporine may be converted to tacrolimus with minimal risk of allograft dysfunction or rejection.

Original languageEnglish (US)
Pages (from-to)1218-1220
Number of pages3
JournalTransplantation
Volume69
Issue number6
StatePublished - Mar 27 2000

Fingerprint

Gingival Hyperplasia
Hirsutism
Tacrolimus
Hypertrichosis
Cyclosporine
Cholesterol
Allografts
Periodontal Index
Glomerular Filtration Rate
Tremor
Hypercholesterolemia
Kidney Transplantation
Immunosuppression
Headache
Diarrhea
Blood Pressure
Kidney

ASJC Scopus subject areas

  • Transplantation
  • Immunology

Cite this

The effect of conversion from cyclosporine to tacrolimus on gingival hyperplasia, hirsutism and cholesterol. / Thorp, Micah; Demattos, Angelo; Bennett, William; Barry, John; Norman, Douglas.

In: Transplantation, Vol. 69, No. 6, 27.03.2000, p. 1218-1220.

Research output: Contribution to journalArticle

@article{f7d8a1383970417a843c47f0ab1059ba,
title = "The effect of conversion from cyclosporine to tacrolimus on gingival hyperplasia, hirsutism and cholesterol",
abstract = "The use of cyclosporine for immunosuppression in renal transplantation allograft recipients is associated with hypertrichosis, gingival hyperplasia, and hypercholesterolemia. Conversion of patients to tacrolimus may lead to an improvement in these effects with minimal risk of rejection or allograft dysfunction. Methods. Sixteen renal transplant recipients were prospectively converted from CsA to tacrolimus and followed for 1 year. Gingival hyperplasia index, total cholesterol, and blood pressure were recorded at the outset, 4-, 8-, and 12-month intervals. Glomerular filtration rate was checked before conversion and 1 year later. Photographs documenting hypertrichosis were taken before conversion and 1 year later. Adverse effects from tacrolimus were recorded at 4, 8, and 12 months. Results. Twelve patients with hypertrichosis noted rapid improvement. Mean gingival hyperplasia index decreased from 24 to 6; mean total cholesterol decreased from 237 to 195. Glomerular filtration rate was essentially unchanged (56 to 54). One episode of rejection occurred, three patients developed diarrhea, three noted headaches, and one had a tremor. Conclusion. If carefully monitored, patients suffering adverse effects secondary to cyclosporine may be converted to tacrolimus with minimal risk of allograft dysfunction or rejection.",
author = "Micah Thorp and Angelo Demattos and William Bennett and John Barry and Douglas Norman",
year = "2000",
month = "3",
day = "27",
language = "English (US)",
volume = "69",
pages = "1218--1220",
journal = "Transplantation",
issn = "0041-1337",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - The effect of conversion from cyclosporine to tacrolimus on gingival hyperplasia, hirsutism and cholesterol

AU - Thorp, Micah

AU - Demattos, Angelo

AU - Bennett, William

AU - Barry, John

AU - Norman, Douglas

PY - 2000/3/27

Y1 - 2000/3/27

N2 - The use of cyclosporine for immunosuppression in renal transplantation allograft recipients is associated with hypertrichosis, gingival hyperplasia, and hypercholesterolemia. Conversion of patients to tacrolimus may lead to an improvement in these effects with minimal risk of rejection or allograft dysfunction. Methods. Sixteen renal transplant recipients were prospectively converted from CsA to tacrolimus and followed for 1 year. Gingival hyperplasia index, total cholesterol, and blood pressure were recorded at the outset, 4-, 8-, and 12-month intervals. Glomerular filtration rate was checked before conversion and 1 year later. Photographs documenting hypertrichosis were taken before conversion and 1 year later. Adverse effects from tacrolimus were recorded at 4, 8, and 12 months. Results. Twelve patients with hypertrichosis noted rapid improvement. Mean gingival hyperplasia index decreased from 24 to 6; mean total cholesterol decreased from 237 to 195. Glomerular filtration rate was essentially unchanged (56 to 54). One episode of rejection occurred, three patients developed diarrhea, three noted headaches, and one had a tremor. Conclusion. If carefully monitored, patients suffering adverse effects secondary to cyclosporine may be converted to tacrolimus with minimal risk of allograft dysfunction or rejection.

AB - The use of cyclosporine for immunosuppression in renal transplantation allograft recipients is associated with hypertrichosis, gingival hyperplasia, and hypercholesterolemia. Conversion of patients to tacrolimus may lead to an improvement in these effects with minimal risk of rejection or allograft dysfunction. Methods. Sixteen renal transplant recipients were prospectively converted from CsA to tacrolimus and followed for 1 year. Gingival hyperplasia index, total cholesterol, and blood pressure were recorded at the outset, 4-, 8-, and 12-month intervals. Glomerular filtration rate was checked before conversion and 1 year later. Photographs documenting hypertrichosis were taken before conversion and 1 year later. Adverse effects from tacrolimus were recorded at 4, 8, and 12 months. Results. Twelve patients with hypertrichosis noted rapid improvement. Mean gingival hyperplasia index decreased from 24 to 6; mean total cholesterol decreased from 237 to 195. Glomerular filtration rate was essentially unchanged (56 to 54). One episode of rejection occurred, three patients developed diarrhea, three noted headaches, and one had a tremor. Conclusion. If carefully monitored, patients suffering adverse effects secondary to cyclosporine may be converted to tacrolimus with minimal risk of allograft dysfunction or rejection.

UR - http://www.scopus.com/inward/record.url?scp=0034719672&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034719672&partnerID=8YFLogxK

M3 - Article

C2 - 10762229

AN - SCOPUS:0034719672

VL - 69

SP - 1218

EP - 1220

JO - Transplantation

JF - Transplantation

SN - 0041-1337

IS - 6

ER -